Xencor, Inc. ( XNCR) - Stock Earnings
XNCR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
XNCR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -6.7 million USD | 28.2 million USD |
| 2026Q1 | -128.9 million USD | 4.5 million USD |
| 2026Q2 | -21.7 million USD | 51.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
XNCR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -126.1 million USD | 168.3 million USD |
| 2024 | -232.6 million USD | 110.5 million USD |
| 2025 | -91.9 million USD | 125.6 million USD |
| 2026 Est. | — | — |
XNCR
Price: $23.88
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 500400
Ebitda: -14.8 millionMarket Capitalization: 1.8 billion